bar
Pennsylvania Department of Drug & Alcohol Programs
Inspection Results

bar

Surveys don't appear on this website until at least 41 days have elapsed since the exit date of the survey.

CARON TREATMENT CENTERS
P.O. BOX 150, GALEN HALL ROAD, BLD 3300
WERNERSVILLE, PA 19565

Inspection Results   Overview    Definitions       Surveys   Additional Services   Search

Survey conducted on 12/19/2011

INITIAL COMMENTS
 
This report is a result of an on-site inspection conducted for the approval to use a narcotic agent, specifically buprenorphine, in the treatment of narcotic addiction. This inspection was conducted on December 19, 2011 by staff from the Division of Drug and Alcohol Program Licensure. Based on the findings of the on-site inspection, Caron Treatment Centers -detox Unit was found not to be in compliance with the applicable chapters of 4 PA Code and 28 PA Code which pertain to the facility. The following deficiencies were identified during this inspection.
 
Plan of Correction

715.9(a)(1)  LICENSURE Intake

(a) Prior to administration of an agent, a narcotic treatment program shall screen each individual to determine eligibility for admission. The narcotic treatment program shall: (1) Verify that the individual has reached 18 years of age.
Observations
Nine patient records were reviewed December 19, 2011. All records required documention that indicated the admitted patients were 18 years of age and older.



The findings include:



Patient # 5 was admitted January 2, 2011. Documentation reviewed in the record identified that the patient was 17 years of age at the time of admission. A urine drug screen was completed January 5, 2011. The patient was administered Subutex, a narcotic agent used in the treatment of opiate addiction, on January 5, 2011.



Patient # 6 was admitted November 21, 2011. Documentation reviewed in the record identified that the patient was 16 years of age at the time of admission. A urine drug screen was completed November 22, 2011. The patient was administered Subutex, a narcotic agent used in the treatment of opiate addiction, on November 22, 2011.
 
Plan of Correction
All adolescents requiring buprenorphine for opioid withdrawal will have a buprenorphine exception completed and faxed to State. Until receiving acknowledgement by the State, the adolescent will be managed with comfort medications for management of withdrawal.



To ensure compliance this is being audited as part of the monthly medical quality audits.



The Director of Nursing is responsible for implementation and the audit process.

 
Pennsylvania Department of Drug and Alcohol Programs Home Page


Copyright @ 2001 Commonwealth of Pennsylvania. All Rights Reserved.
Commonwealth of PA Privacy Statement